Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.

International journal of oncology

Volumn 23, Issue 2, 2003, Pages 369-380

  Liang, Yayun ^a   Hou, Min ^a   Kallab, Andre M ^a   Barrett, John T ^a   El Etreby, Fathy ^a   Schoenlein, Patricia V ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; 4-HYDROXYTAMOXIFEN; ANTIESTROGEN; CASPASE; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; CYTOCHROME C; DRUG DERIVATIVE; ESTROGEN RECEPTOR; MIFEPRISTONE; RETINOBLASTOMA PROTEIN; TAMOXIFEN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL DIVISION; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; METABOLISM; PATHOLOGY; UPREGULATION;

APOPTOSIS; BREAST NEOPLASMS; CASPASES; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; CYTOCHROMES C; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MIFEPRISTONE; RECEPTORS, ESTROGEN; RETINOBLASTOMA PROTEIN; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 1542392638     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)